Story perspectives

LSD Breakthrough: New Hope for Anxiety Treatment?

9/7/2025

34 2

Summary

Story summary

A study suggests LSD may reduce anxiety, showing potential for generalized anxiety disorder treatment.
Mind Medicine Inc. conducted the trial with 198 participants receiving different LSD doses or a placebo.
Those on a 100-microgram dose experienced a 21-point decrease in anxiety scores lasting up to 12 weeks.
Nearly half on higher doses achieved remission, with only mild side effects noted.
The FDA designated Mind Medicine’s LSD formulation as a breakthrough therapy in 2024.
Critics point out trial blinding issues and the need for specialized therapy environments.
Successful phase III trials could revolutionize anxiety treatment for 26 million Americans.

1 of 1

Story summary

A study suggests LSD may reduce anxiety, showing potential for generalized anxiety disorder treatment.
Mind Medicine Inc. conducted the trial with 198 participants receiving different LSD doses or a placebo.
Those on a 100-microgram dose experienced a 21-point decrease in anxiety scores lasting up to 12 weeks.
Nearly half on higher doses achieved remission, with only mild side effects noted.
The FDA designated Mind Medicine’s LSD formulation as a breakthrough therapy in 2024.
Critics point out trial blinding issues and the need for specialized therapy environments.
Successful phase III trials could revolutionize anxiety treatment for 26 million Americans.